FBXW11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.80980008757103E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.9832999999545E-06 |
Normal-vs-Stage2 |
1.57316999999102E-05 |
Normal-vs-Stage3 |
7.40851824332367E-13 |
Normal-vs-Stage4 |
3.92808008342627E-12 |
Stage1-vs-Stage2 |
1.981380E-01 |
Stage1-vs-Stage3 |
3.59020000000321E-05 |
Stage1-vs-Stage4 |
4.1752000000006E-05 |
Stage2-vs-Stage3 |
9.915600E-02 |
Stage2-vs-Stage4 |
6.072400E-02 |
Stage3-vs-Stage4 |
6.603200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.80659981103327E-10 |
Normal-vs-AfricanAmerican |
9.12919995155193E-09 |
Normal-vs-Asian |
2.116300E-02 |
Caucasian-vs-AfricanAmerican |
3.024600E-01 |
Caucasian-vs-Asian |
9.485000E-01 |
AfricanAmerican-vs-Asian |
6.016200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.87609968963443E-11 |
Normal-vs-Female |
1.39349999983551E-07 |
Male-vs-Female |
1.431230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.14049999999644E-06 |
Normal-vs-Age(41-60Yrs) |
8.7871000031825E-08 |
Normal-vs-Age(61-80Yrs) |
1.44020018133517E-10 |
Normal-vs-Age(81-100Yrs) |
1.011000E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.891620E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.573200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.270000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.799600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.318800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.004200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.940030E-01 |
Normal-vs-Grade 2 |
8.79380000040619E-07 |
Normal-vs-Grade 3 |
1.01279995501358E-09 |
Normal-vs-Grade 4 |
1.63258295771129E-12 |
Grade 1-vs-Grade 2 |
2.892400E-01 |
Grade 1-vs-Grade 3 |
8.066200E-02 |
Grade 1-vs-Grade 4 |
1.115150E-03 |
Grade 2-vs-Grade 3 |
3.030100E-02 |
Grade 2-vs-Grade 4 |
2.85379999998003E-06 |
Grade 3-vs-Grade 4 |
4.982900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.401400E-04 |
Normal-vs-ccB subtype |
5.35079758279267E-11 |
ccA subtype-vs-ccB subtype |
2.15189999999144E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.9283999931381E-09 |
Normal-vs-N1 |
2.24239999999654E-05 |
N0-vs-N1 |
1.499640E-01 |
|
|